Investigation of ERCC2 Mutations Through Generation and Analysis of Genetically Modified Cell Lines
This thesis aims to investigate the impact of ERCC2 mutations and their role in the Nucleotide Excision Repair (NER) DNA repair mechanism. Using genetically modified MCF10A cell lines with an inducible Cas9, the study explores how these mutations affect cellular sensitivity to cisplatin, a chemotherapy drug. CRISPR-Cas9 technology was employed in an attempt to generate monoallelic cell lines with
